ASRM/LinkedIn
May 18, 2026, 11:17
ASRM Responds to Supreme Court Mifepristone Decision – ASRM
American Society for Reproductive Medicine – ASRM shared a post on LinkedIn:
“While not a final decision, ASRM is pleased that the Supreme Court’s ruling will allow patients continued access to mifepristone. As the case continues to unfold, ASRM urges the Court to respect scientific evidence and FDA authority.
See Dr. Brannigan’s full statement.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 18, 2026, 11:38Inshirah Sgayer: Happy to Share Our New Publication on Unstable Fetal Lie
-
May 18, 2026, 11:27Join Us for Insightful Conversations on FRMC 2026 – Center for Human Reproduction
-
May 18, 2026, 11:19Devyanshi Dixit: PCOS and Hormonal Disorders, Advancing Precision Care in Women’s Endocrine Health
-
May 18, 2026, 11:12Nibhash Kumar: Can an Intact Acrosome During ICSI Contribute to Fertilization Failure?
-
May 18, 2026, 11:05Hope Alicia: Fertility Show 2026 Highlights the Importance of Patient Support and Education
-
May 18, 2026, 11:02$10,000 Prize Announced for 2026 ASRM INNOVATE Pitch Tank Showcase – ASRM
-
May 18, 2026, 07:09Why “Just Keep Trying” is Bad Advice if You’re Under 38 with Unexplained Infertility – Fertility Plus
-
May 18, 2026, 06:37Sandro Esteves: “Merging Galaxies” at the POSEIDON and APHRODITE Conference
-
May 18, 2026, 06:31Marco Zaccaria: ESGE Announces Basic Hysteroscopy Course for OBGYNs Seeking Practical Training